Literature DB >> 10572262

Inositol synthesis and catabolism in Cryptococcus neoformans.

Y Molina1, S E Ramos, T Douglass, L S Klig.   

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that synthesizes and catabolizes inositol. This study demonstrates inositol synthesis from glucose-6-phosphate via inositol-1-phosphate synthase and catabolism to glucuronic acid via inositol oxygenase in this organism. These inositol synthetic and catabolic pathways are regulated in opposition; repressing conditions for one are inducing conditions for the other. An inositol-requiring strain was generated by UV mutagenesis. Without inositol, this mutant strain undergoes 'inositol-less' death, during which time the phosphatidylinositol composition of the membranes decreases without alteration of the proportion of other phospholipids. The mutation on this strain results in no detectable inositol synthetic activity but normal (wild-type) inositol catabolic activity. This inositol-requiring mutant strain reverted at a high frequency. Classical genetic experiments revealed that the majority of the reverting mutations are at second sites. Interestingly, the revertants exhibited unusual morphological phenotypes when deprived of inositol, while provision of inositol restored wild-type morphology. Inositol metabolism is clearly important for growth and development of C. neoformans and may be involved in this organism's mechanism for survival as both a saprophyte in soil and a parasite in humans. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572262     DOI: 10.1002/(SICI)1097-0061(199911)15:15<1657::AID-YEA493>3.0.CO;2-3

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  9 in total

1.  PCR screening and sequence analysis of iol clusters in Lactobacillus casei strains isolated from koumiss.

Authors:  W Zhang; Z Sun; T Sun; H Zhang
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

2.  Two major inositol transporters and their role in cryptococcal virulence.

Authors:  Yina Wang; Tong-bao Liu; Guillaume Delmas; Steven Park; David Perlin; Chaoyang Xue
Journal:  Eukaryot Cell       Date:  2011-03-11

3.  myo-inositol oxygenase offers a possible entry point into plant ascorbate biosynthesis.

Authors:  Argelia Lorence; Boris I Chevone; Pedro Mendes; Craig L Nessler
Journal:  Plant Physiol       Date:  2004-02-19       Impact factor: 8.340

4.  Finding the sweet spot: how human fungal pathogens acquire and turn the sugar inositol against their hosts.

Authors:  Chaoyang Xue
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

5.  Regulated inositol synthesis is critical for balanced metabolism and development in Drosophila melanogaster.

Authors:  Maria J Rivera; Altagracia Contreras; LongThy T Nguyen; Elizabeth D Eldon; Lisa S Klig
Journal:  Biol Open       Date:  2021-10-28       Impact factor: 2.422

Review 6.  Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it.

Authors:  Todd B Reynolds
Journal:  Microbiology (Reading)       Date:  2009-04-21       Impact factor: 2.777

7.  Computational modeling and in silico analysis of differential regulation of myo-inositol catabolic enzymes in Cryptococcus neoformans.

Authors:  Emalee A Mackenzie; Lisa S Klig
Journal:  BMC Mol Biol       Date:  2008-10-14       Impact factor: 2.946

8.  Extensive Metabolic Remodeling Differentiates Non-pathogenic and Pathogenic Growth Forms of the Dimorphic Pathogen Talaromyces marneffei.

Authors:  Shivani Pasricha; James I MacRae; Hwa H Chua; Jenny Chambers; Kylie J Boyce; Malcolm J McConville; Alex Andrianopoulos
Journal:  Front Cell Infect Microbiol       Date:  2017-08-17       Impact factor: 5.293

9.  Disruption of INOS, a Gene Encoding myo-Inositol Phosphate Synthase, Causes Male Sterility in Drosophila melanogaster.

Authors:  Natasha A M Jackson; Angelina M Flores; Elizabeth D Eldon; Lisa S Klig
Journal:  G3 (Bethesda)       Date:  2018-08-30       Impact factor: 3.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.